Last reviewed · How we verify

NCT04169646: NEXpro

Prevention and Intervention of Neck Pain in Swiss Office-Workers

Completed NA Last updated 22 March 2023
What this trial tests

NA trial testing Multi-component intervention in Neck Pain in 120 participants. Completed in 31 July 2022.

Timeline
28 October 2019
Primary endpoint
31 July 2022
31 July 2022

Quick facts

Lead sponsorZurich University of Applied Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment120
Start date28 October 2019
Primary completion31 July 2022
Estimated completion31 July 2022
Sites2 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Zurich University of Applied Sciences

Who can join

Adults 18 to 65, any sex, with Neck Pain or Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is the first that investigates the impact of a multi-component intervention combining current evidence of effective interventions with an adherence app to assess the potential benefits on productivity, neck pain, and headache.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.
    Aegerter AM, Deforth M, Sjøgaard G, Johnston V, et al · · 2021 · cited 21× · PMID 33688857 · DOI 10.3389/fpsyg.2021.620307
  2. No evidence for an effect of working from home on neck pain and neck disability among Swiss office workers: Short-term impact of COVID-19.
    Aegerter AM, Deforth M, Johnston V, Sjøgaard G, et al · · 2021 · cited 20× · PMID 33817763 · DOI 10.1007/s00586-021-06829-w
  3. On-site multi-component intervention to improve productivity and reduce the economic and personal burden of neck pain in Swiss office-workers (NEXpro): protocol for a cluster-randomized controlled trial.
    Aegerter AM, Deforth M, Johnston V, Ernst MJ, et al · · 2020 · cited 18× · PMID 32560714 · DOI 10.1186/s12891-020-03388-x
  4. A Multi-component Intervention (NEXpro) Reduces Neck Pain-Related Work Productivity Loss: A Randomized Controlled Trial Among Swiss Office Workers.
    Aegerter AM, Deforth M, Volken T, Johnston V, et al · · 2023 · cited 12× · PMID 36167936 · DOI 10.1007/s10926-022-10069-0
  5. Cost-utility and cost-benefit analysis of a multi-component intervention (NEXpro) for neck-related symptoms in Swiss office workers.
    Brunner B, Aegerter AM, Johnston V, Volken T, et al · · 2025 · cited 3× · PMID 39815202 · DOI 10.1186/s12889-024-21103-6
  6. Effects of neck-exercise and health promotion on headache outcomes in office workers: secondary analysis of the NEXpro stepped wedge cluster randomised controlled trial.
    Ernst MJ, Meichtry A, Luedtke K, NEXpro collaboration group, et al · · 2025 · cited 2× · PMID 39939850 · DOI 10.1186/s10194-025-01963-y
  7. Headache, not neck pain, primarily influences the extent of pain in the neck region in symptomatic office workers. Cross-sectional and longitudinal evaluations.
    Marchenko M, Domingues L, Barbero M, Cescon C, et al · · 2026 · PMID 41384674 · DOI 10.1080/09593985.2025.2596179
  8. A multi-component intervention (NEXpro) reduces neck pain: a randomized controlled trial among Swiss office workers.
    Aegerter AM, Johnston V, Volken T, Sjøgaard G, et al · · 2026 · PMID 41037652 · DOI 10.5271/sjweh.4254

Verify or expand the search:

Other trials of Multi-component intervention

Trials testing the same drug.

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other Zurich University of Applied Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing